KalVista Pharmaceuticals, Inc. Insider Transactions
KalVista Pharmaceuticals, Inc. Insider Trades History
| Insider Name | Buy/Sell | Shares Bought/Sold @ Price |
Total Transaction | Shares Held After Transaction |
Transaction Date | Filing Date | Details |
|---|---|---|---|---|---|---|---|
|
Audhya Paul K.
CHIEF MEDICAL OFFICER |
Sell | 8,077 @ $9.26 | $74.77 K | 94,199 | 11/18/2024 | 11/19/2024 | |
|
Palleiko Benjamin L
Director, CHIEF EXECUTIVE OFFICER |
Sell | 7,352 @ $12.19 | $89.62 K | 250,800 | 09/09/2024 | 09/10/2024 | |
|
Audhya Paul K.
CHIEF MEDICAL OFFICER |
Sell | 2,135 @ $12.40 | $26.47 K | 83,745 | 08/23/2024 | 08/26/2024 | |
|
Yea Christopher
CHIEF DEVELOPMENT OFFICER |
Sell | 1,916 @ $12.40 | $23.76 K | 85,676 | 08/23/2024 | 08/26/2024 | |
|
Audhya Paul K.
CHIEF MEDICAL OFFICER |
Sell | 7,973 @ $12.01 | $95.78 K | 80,880 | 08/19/2024 | 08/21/2024 | |
|
Palleiko Benjamin L
Director, CHIEF EXECUTIVE OFFICER |
Sell | 14,215 @ $12.01 | $170.77 K | 242,527 | 08/19/2024 | 08/21/2024 | |
|
Yea Christopher
CHIEF DEVELOPMENT OFFICER |
Sell | 7,102 @ $12.01 | $85.32 K | 84,467 | 08/19/2024 | 08/21/2024 | |
|
Palleiko Benjamin L
Director, CHIEF EXECUTIVE OFFICER |
Sell | 7,465 @ $11.53 | $86.07 K | 224,547 | 06/07/2024 | 06/10/2024 | |
|
Feener Edward P.
CHIEF SCIENTIFIC OFFICER |
Sell | 8,088 @ $11.76 | $95.15 K | 72,858 | 05/20/2024 | 05/21/2024 |
KalVista Pharmaceuticals, Inc. FAQ's
The list of insiders at KalVista Pharmaceuticals, Inc. includes Palleiko Benjamin L, Venrock Healthcare Capital Partners III, L.P., Yea Christopher, Audhya Paul K..
Insiders have sold a total of 29.44 K KalVista Pharmaceuticals, Inc. shares in the last 12 months for a total of 303.79 K sold.
The following insiders have sold KalVista Pharmaceuticals, Inc. shares in the last 12 months: Palleiko Benjamin L ($204.33 K), Yea Christopher ($44.77 K), Audhya Paul K. ($54.69 K),
Insiders have purchased a total of 361.21 K KalVista Pharmaceuticals, Inc. shares in the last 12 months for a total of 3.32 M.
The following insiders have purchased KalVista Pharmaceuticals, Inc. shares in the last 12 months: Venrock Healthcare Capital Partners III, L.P. ($3.32 M),